These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18174012)

  • 21. Analysis of failures in patients with FIGO stage IIIc1-IIIc2 endometrial cancer.
    Gadducci A; Cosio S; Fabrini MG; Guerrieri ME; Greco C; Genazzani AR
    Anticancer Res; 2012 Jan; 32(1):201-5. PubMed ID: 22213308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current treatment strategies for endometrial cancer.
    Fiorelli JL; Herzog TJ; Wright JD
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1149-57. PubMed ID: 18588459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
    Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
    Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of FIGO Stage IIIc endometrial cancer patients.
    McMeekin DS; Lashbrook D; Gold M; Johnson G; Walker JL; Mannel R
    Gynecol Oncol; 2001 May; 81(2):273-8. PubMed ID: 11330962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A contemporary review of uterine cancer management.
    Carter J
    Aust N Z J Obstet Gynaecol; 2013 Dec; 53(6):517-24. PubMed ID: 23829412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of endometrial cancer in Italy: a national survey endorsed by the Italian Society of Gynecologic Oncology.
    Greggi S; Franchi M; Aletti G; Biglia N; Ditto A; Fagotti A; Giorda G; Mangili G; Odicino F; Salerno MG; Vizza E; Scaffa C; Scollo P
    Int J Surg; 2014 Oct; 12(10):1038-44. PubMed ID: 25150805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
    Akbayır O; Corbacıoglu Esmer A; Numanoglu C; Cılesız Goksedef BP; Akca A; Bakır LV; Kuru O
    Arch Gynecol Obstet; 2012 Nov; 286(5):1269-76. PubMed ID: 22729137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical staging for patients presenting with grade 1 endometrial carcinoma.
    Ben-Shachar I; Pavelka J; Cohn DE; Copeland LJ; Ramirez N; Manolitsas T; Fowler JM
    Obstet Gynecol; 2005 Mar; 105(3):487-93. PubMed ID: 15738013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
    Ayhan A; Taskiran C; Celik C; Yuce K
    Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of endometrial cancer].
    Pfleiderer A
    Geburtshilfe Frauenheilkd; 1991 Oct; 51(10):787-97. PubMed ID: 1761167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy.
    Mariani A; Dowdy SC; Keeney GL; Long HJ; Lesnick TG; Podratz KC
    Gynecol Oncol; 2004 Oct; 95(1):120-6. PubMed ID: 15385120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of early-stage endometrial cancer.
    Lu KH
    Semin Oncol; 2009 Apr; 36(2):137-44. PubMed ID: 19332248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The evolving role of adjuvant therapy in endometrial cancer.
    Gadducci A; Greco C
    Crit Rev Oncol Hematol; 2011 May; 78(2):79-91. PubMed ID: 20418109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combined treatment and prognostic factors for stage III and IV endometrial carcinoma].
    Ren YL; Wang HY; Shi DR; Yang WT; Sun Z; Chen Y
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):523-7. PubMed ID: 19080517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Issues surrounding lymphadenectomy in the management of endometrial cancer.
    Bernardini MQ; Murphy JK
    J Surg Oncol; 2009 Mar; 99(4):232-41. PubMed ID: 19072933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
    Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
    Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endometrial carcinoma: analysis of recurrence in patients treated with a strategy minimizing lymph node sampling and radiation therapy.
    Kim YB; Niloff JM
    Obstet Gynecol; 1993 Aug; 82(2):175-80. PubMed ID: 8336860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.